[E-Daily Reporter Shin Ha-yeon ] Quratis Inc.(348080)announced on the 20th that it has signed a contract with Access to Advanced Health (UK) Ltd to supply clinical-stage pharmaceuticals worth 24.8916 billion won. This amount represents 101.31% of the company’s recent revenue. The contract is valid through June 30, 2030.
Disclosure Plus
Quratis Inc. Signs Supply Contract Worth 2.49 Billion
Economy
Corporation
IT·Science
Economy
Money Flows into AI Side Effects… Investment in Verified Startups Booms in Europe
As the spread of fraud and misinformation using artificial intelligence (AI) continues to rise, investment is flowing into European startups that verify AI-generated content. The scope of investment i…
Corporation
Curocell Inc.’s “Limcato” to Be Covered by National Health Insurance Starting in December… Price Per Dose: 280 Million Won
“Limcato,” developed by Curocell Inc. and Korea’s first domestically produced chimeric antigen receptor T-cell (CAR-T) therapy, is set to be covered by the National Health Insurance. This is expected …
IT·Science
CJ ENM CO., Ltd. Files for Preliminary Injunction to Halt LG HelloVision Channel Broadcasts… “We Will Protect Viewers’ Right to Choose”
CJ ENM CO., Ltd.(035760)has filed a petition for a preliminary injunction with the court, asking it to prevent LG HelloVision(037560)from suspending broadcasts on its four channels.
(Photo: CJ ENM …